Watson Bio: due to the adjustment of shareholding mode, the chairman and vice chairman transferred a total of 3.5367 million shares to Chengdu Xiyun
Watson biological announced that the company today received a letter of notification from Chairman Li Yunchun and vice chairman Huang Zhen. Due to the adjustment of shareholding mode, Li Yunchun transferred 2.5367 million shares of Watson biology to Chengdu Xiyun enterprise management partnership (limited partnership) through block trading on June 2, 2021 at the price of 69.84 yuan / share. On the same day, Huangzhen transferred its 1 million shares of Watson biology to Chengdu Xiyun at the price of 69.84 yuan / share through block trading.
This text is a result of machine translation.
Related companies：
In-depth
Dec 11, 2023 08:49 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Watson biology: 13 valent pneumococcal polysaccharide conjugate vaccine has been licensed in Morocco
Briefing Dec 12, 2021 05:48 PM
· Healthcare
Watson biology: Yuxi Watson plans to invest in the production and capacity expansion project of polysaccharide conjugate vaccine, with a total investment of 695 million yuan
Consumer Staples
Muyuan Announces Plan to List on the Hong Kong Stock Exchange
Apr 17, 2025 01:34 PM
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Briefing Jul 29, 2021 10:01 AM
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%
See more
Read next
Insight
In-depth
Automotive · Analysis
Chinese Automakers Break into a €10 Billion Market in Europe
Apr 11, 2025 09:57 PM
Insight
In-depth
Automotive · Analysis
Tariff Escalation Through the Lens of Geopolitical Economy
Apr 11, 2025 12:32 PM
Insight
In-depth
Consumer Staples · Analysis
China’s “Dark Cuisine” and Southeast Asia’s Wealth Code
Apr 07, 2025 03:46 PM
Insight
In-depth
